ArticleMolecular cancer therapeutics2020

Phase I, Pharmacogenomic, Drug Interaction Study of Sorafenib and Bevacizumab in Combination with Paclitaxel in Patients with Advanced Refractory Solid Tumors.

E Gabriela Chiorean et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.